Advanced search options

Advanced Search Options 🞨

Browse by author name (“Author name starts with…”).

Find ETDs with:

in
/  
in
/  
in
/  
in

Written in Published in Earliest date Latest date

Sorted by

Results per page:

Sorted by: relevance · author · university · dateNew search

You searched for subject:(rivaroxaban). Showing records 1 – 26 of 26 total matches.

Search Limiters

Last 2 Years | English Only

No search limiters apply to these results.

▼ Search Limiters

1. Garabon, Justin John William. Impact of Thrombomodulin and Thrombin-Activatable Fibrinolysis Inhibitor on the Anticoagulant and Profibrinolytic Effects of Rivaroxaban.

Degree: MS, Chemistry and Biochemistry, 2016, University of Windsor

Rivaroxaban is a direct factor Xa inhibitor, recently implemented as a favorable alternative to warfarin in anticoagulation therapy. Rivaroxaban effectively reduces thrombin generation, which plays… (more)

Subjects/Keywords: Fibrinolysis; Rivaroxaban; TAFI

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Garabon, J. J. W. (2016). Impact of Thrombomodulin and Thrombin-Activatable Fibrinolysis Inhibitor on the Anticoagulant and Profibrinolytic Effects of Rivaroxaban. (Masters Thesis). University of Windsor. Retrieved from https://scholar.uwindsor.ca/etd/5822

Chicago Manual of Style (16th Edition):

Garabon, Justin John William. “Impact of Thrombomodulin and Thrombin-Activatable Fibrinolysis Inhibitor on the Anticoagulant and Profibrinolytic Effects of Rivaroxaban.” 2016. Masters Thesis, University of Windsor. Accessed July 21, 2019. https://scholar.uwindsor.ca/etd/5822.

MLA Handbook (7th Edition):

Garabon, Justin John William. “Impact of Thrombomodulin and Thrombin-Activatable Fibrinolysis Inhibitor on the Anticoagulant and Profibrinolytic Effects of Rivaroxaban.” 2016. Web. 21 Jul 2019.

Vancouver:

Garabon JJW. Impact of Thrombomodulin and Thrombin-Activatable Fibrinolysis Inhibitor on the Anticoagulant and Profibrinolytic Effects of Rivaroxaban. [Internet] [Masters thesis]. University of Windsor; 2016. [cited 2019 Jul 21]. Available from: https://scholar.uwindsor.ca/etd/5822.

Council of Science Editors:

Garabon JJW. Impact of Thrombomodulin and Thrombin-Activatable Fibrinolysis Inhibitor on the Anticoagulant and Profibrinolytic Effects of Rivaroxaban. [Masters Thesis]. University of Windsor; 2016. Available from: https://scholar.uwindsor.ca/etd/5822


University of Minnesota

2. Baumann Kreuziger, Lisa M. Management of bleeding associated with dabigatran and rivaroxaban: a survey of current practices.

Degree: 2013, University of Minnesota

University of Minnesota M.S. thesis. Major: Clinical Research. May 2013. Advisor: Mark T. Reding. 1 computer file (PDF); vi, 36 pages.

Dabigatran and rivaroxaban are… (more)

Subjects/Keywords: Anticoagulation; Dabigatran; Hemorrhage; Rivaroxaban

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Baumann Kreuziger, L. M. (2013). Management of bleeding associated with dabigatran and rivaroxaban: a survey of current practices. (Masters Thesis). University of Minnesota. Retrieved from http://purl.umn.edu/156571

Chicago Manual of Style (16th Edition):

Baumann Kreuziger, Lisa M. “Management of bleeding associated with dabigatran and rivaroxaban: a survey of current practices.” 2013. Masters Thesis, University of Minnesota. Accessed July 21, 2019. http://purl.umn.edu/156571.

MLA Handbook (7th Edition):

Baumann Kreuziger, Lisa M. “Management of bleeding associated with dabigatran and rivaroxaban: a survey of current practices.” 2013. Web. 21 Jul 2019.

Vancouver:

Baumann Kreuziger LM. Management of bleeding associated with dabigatran and rivaroxaban: a survey of current practices. [Internet] [Masters thesis]. University of Minnesota; 2013. [cited 2019 Jul 21]. Available from: http://purl.umn.edu/156571.

Council of Science Editors:

Baumann Kreuziger LM. Management of bleeding associated with dabigatran and rivaroxaban: a survey of current practices. [Masters Thesis]. University of Minnesota; 2013. Available from: http://purl.umn.edu/156571


University of Debrecen

3. Vasali, Zsuzsa. Az új típusú orális antikoagulánsok helye és jelentősége a farmakoterápiában .

Degree: DE – Gyógyszerésztudományi Kar, University of Debrecen

 Az antikoaguláns kezelés célja a trombusképződés prevenciója, akut trombózisban pedig a trombus további növekedésének megakadályozása, ugyanis a trombózis életveszélyes lehet, és megfelelő antikoaguláns kezelést igényel.… (more)

Subjects/Keywords: rivaroxaban; dabigatran

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Vasali, Z. (n.d.). Az új típusú orális antikoagulánsok helye és jelentősége a farmakoterápiában . (Thesis). University of Debrecen. Retrieved from http://hdl.handle.net/2437/240734

Note: this citation may be lacking information needed for this citation format:
No year of publication.
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Vasali, Zsuzsa. “Az új típusú orális antikoagulánsok helye és jelentősége a farmakoterápiában .” Thesis, University of Debrecen. Accessed July 21, 2019. http://hdl.handle.net/2437/240734.

Note: this citation may be lacking information needed for this citation format:
No year of publication.
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Vasali, Zsuzsa. “Az új típusú orális antikoagulánsok helye és jelentősége a farmakoterápiában .” Web. 21 Jul 2019.

Note: this citation may be lacking information needed for this citation format:
No year of publication.

Vancouver:

Vasali Z. Az új típusú orális antikoagulánsok helye és jelentősége a farmakoterápiában . [Internet] [Thesis]. University of Debrecen; [cited 2019 Jul 21]. Available from: http://hdl.handle.net/2437/240734.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
No year of publication.

Council of Science Editors:

Vasali Z. Az új típusú orális antikoagulánsok helye és jelentősége a farmakoterápiában . [Thesis]. University of Debrecen; Available from: http://hdl.handle.net/2437/240734

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
No year of publication.


University of Minnesota

4. Baumann Kreuziger, Lisa M. Management of bleeding associated with dabigatran and rivaroxaban: a survey of current practices.

Degree: MS, Clinical Research, 2013, University of Minnesota

 Dabigatran and rivaroxaban are two new oral anticoagulants that have been recently approved as alternatives to warfarin. Clinical trials have shown non-inferiority of the new… (more)

Subjects/Keywords: Anticoagulation; Dabigatran; Hemorrhage; Rivaroxaban

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Baumann Kreuziger, L. M. (2013). Management of bleeding associated with dabigatran and rivaroxaban: a survey of current practices. (Masters Thesis). University of Minnesota. Retrieved from http://purl.umn.edu/156571

Chicago Manual of Style (16th Edition):

Baumann Kreuziger, Lisa M. “Management of bleeding associated with dabigatran and rivaroxaban: a survey of current practices.” 2013. Masters Thesis, University of Minnesota. Accessed July 21, 2019. http://purl.umn.edu/156571.

MLA Handbook (7th Edition):

Baumann Kreuziger, Lisa M. “Management of bleeding associated with dabigatran and rivaroxaban: a survey of current practices.” 2013. Web. 21 Jul 2019.

Vancouver:

Baumann Kreuziger LM. Management of bleeding associated with dabigatran and rivaroxaban: a survey of current practices. [Internet] [Masters thesis]. University of Minnesota; 2013. [cited 2019 Jul 21]. Available from: http://purl.umn.edu/156571.

Council of Science Editors:

Baumann Kreuziger LM. Management of bleeding associated with dabigatran and rivaroxaban: a survey of current practices. [Masters Thesis]. University of Minnesota; 2013. Available from: http://purl.umn.edu/156571


University of Debrecen

5. Khatib, Amin. The New Oral Anticoagulants .

Degree: DE – Általános Orvostudományi Kar, 2014, University of Debrecen

 The new oral anticoagulants were recently developed, which are very specific in their action. They are easy to administer, do not require routine monitoring, and… (more)

Subjects/Keywords: new oral anticoagulants; dabigatran; rivaroxaban; apixaban

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Khatib, A. (2014). The New Oral Anticoagulants . (Thesis). University of Debrecen. Retrieved from http://hdl.handle.net/2437/194734

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Khatib, Amin. “The New Oral Anticoagulants .” 2014. Thesis, University of Debrecen. Accessed July 21, 2019. http://hdl.handle.net/2437/194734.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Khatib, Amin. “The New Oral Anticoagulants .” 2014. Web. 21 Jul 2019.

Vancouver:

Khatib A. The New Oral Anticoagulants . [Internet] [Thesis]. University of Debrecen; 2014. [cited 2019 Jul 21]. Available from: http://hdl.handle.net/2437/194734.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Khatib A. The New Oral Anticoagulants . [Thesis]. University of Debrecen; 2014. Available from: http://hdl.handle.net/2437/194734

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Texas – Austin

6. Goble, Joseph Adam. Impact of CYP3A4/P-gp interacting medications on clinical outcomes in nonvalvular atrial fibrillation patients managed on rivaroxaban.

Degree: Pharmaceutical Sciences, 2018, University of Texas – Austin

 Objectives: To analyze concurrent drug use and its association with outcomes in nonvalvular atrial fibrillation patients receiving rivaroxaban. Methods: We included patients ≥ 18 years… (more)

Subjects/Keywords: Rivaroxaban; DOAC; Atrial fibrillation; Bleed; Thromboembolism

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Goble, J. A. (2018). Impact of CYP3A4/P-gp interacting medications on clinical outcomes in nonvalvular atrial fibrillation patients managed on rivaroxaban. (Thesis). University of Texas – Austin. Retrieved from http://hdl.handle.net/2152/72728

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Goble, Joseph Adam. “Impact of CYP3A4/P-gp interacting medications on clinical outcomes in nonvalvular atrial fibrillation patients managed on rivaroxaban.” 2018. Thesis, University of Texas – Austin. Accessed July 21, 2019. http://hdl.handle.net/2152/72728.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Goble, Joseph Adam. “Impact of CYP3A4/P-gp interacting medications on clinical outcomes in nonvalvular atrial fibrillation patients managed on rivaroxaban.” 2018. Web. 21 Jul 2019.

Vancouver:

Goble JA. Impact of CYP3A4/P-gp interacting medications on clinical outcomes in nonvalvular atrial fibrillation patients managed on rivaroxaban. [Internet] [Thesis]. University of Texas – Austin; 2018. [cited 2019 Jul 21]. Available from: http://hdl.handle.net/2152/72728.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Goble JA. Impact of CYP3A4/P-gp interacting medications on clinical outcomes in nonvalvular atrial fibrillation patients managed on rivaroxaban. [Thesis]. University of Texas – Austin; 2018. Available from: http://hdl.handle.net/2152/72728

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Universidade do Rio Grande do Sul

7. Wingert, Nathalie Ribeiro. Desenvolvimento e validação de métodos analíticos e estudos de estabilidade da rivaroxabana.

Degree: 2015, Universidade do Rio Grande do Sul

A análise de fármacos é fundamental nas diversas fases do desenvolvimento farmacêutico, tais como estudos de formulação, estabilidade e controle de qualidade do produto. A… (more)

Subjects/Keywords: Rivaroxaban; Farmácia; HPLC; UPLC-MS/MS; Degradation product identification; CE; IVIVC

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Wingert, N. R. (2015). Desenvolvimento e validação de métodos analíticos e estudos de estabilidade da rivaroxabana. (Thesis). Universidade do Rio Grande do Sul. Retrieved from http://hdl.handle.net/10183/149500

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Wingert, Nathalie Ribeiro. “Desenvolvimento e validação de métodos analíticos e estudos de estabilidade da rivaroxabana.” 2015. Thesis, Universidade do Rio Grande do Sul. Accessed July 21, 2019. http://hdl.handle.net/10183/149500.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Wingert, Nathalie Ribeiro. “Desenvolvimento e validação de métodos analíticos e estudos de estabilidade da rivaroxabana.” 2015. Web. 21 Jul 2019.

Vancouver:

Wingert NR. Desenvolvimento e validação de métodos analíticos e estudos de estabilidade da rivaroxabana. [Internet] [Thesis]. Universidade do Rio Grande do Sul; 2015. [cited 2019 Jul 21]. Available from: http://hdl.handle.net/10183/149500.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Wingert NR. Desenvolvimento e validação de métodos analíticos e estudos de estabilidade da rivaroxabana. [Thesis]. Universidade do Rio Grande do Sul; 2015. Available from: http://hdl.handle.net/10183/149500

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Aristotle University Of Thessaloniki (AUTH); Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης (ΑΠΘ)

8. Kapetanou, Artemis. Η επίδραση των από του στόματος χορηγούμενων αντιπηκτικών φαρμάκων στην οστική ενσωμάτωση ορθοπαιδικών εμφυτευμάτων: πειραματική μελέτη σε επίμυες.

Degree: 2017, Aristotle University Of Thessaloniki (AUTH); Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης (ΑΠΘ)

Thromboprophylaxis reduces the risk of surgery related deep venous thrombosis and pulmonary embolism. The classical anticoagulants (heparin and low weight molecular heparins) were associated with… (more)

Subjects/Keywords: Οστεοενσωμάτωση; Θρομβοπροφύλαξη; Αντιπηκτικά από του στόματος; Εμφυτεύματα; Osseointegration; thromboprophylaxis; Rivaroxaban; Implants

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Kapetanou, A. (2017). Η επίδραση των από του στόματος χορηγούμενων αντιπηκτικών φαρμάκων στην οστική ενσωμάτωση ορθοπαιδικών εμφυτευμάτων: πειραματική μελέτη σε επίμυες. (Thesis). Aristotle University Of Thessaloniki (AUTH); Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης (ΑΠΘ). Retrieved from http://hdl.handle.net/10442/hedi/41005

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Kapetanou, Artemis. “Η επίδραση των από του στόματος χορηγούμενων αντιπηκτικών φαρμάκων στην οστική ενσωμάτωση ορθοπαιδικών εμφυτευμάτων: πειραματική μελέτη σε επίμυες.” 2017. Thesis, Aristotle University Of Thessaloniki (AUTH); Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης (ΑΠΘ). Accessed July 21, 2019. http://hdl.handle.net/10442/hedi/41005.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Kapetanou, Artemis. “Η επίδραση των από του στόματος χορηγούμενων αντιπηκτικών φαρμάκων στην οστική ενσωμάτωση ορθοπαιδικών εμφυτευμάτων: πειραματική μελέτη σε επίμυες.” 2017. Web. 21 Jul 2019.

Vancouver:

Kapetanou A. Η επίδραση των από του στόματος χορηγούμενων αντιπηκτικών φαρμάκων στην οστική ενσωμάτωση ορθοπαιδικών εμφυτευμάτων: πειραματική μελέτη σε επίμυες. [Internet] [Thesis]. Aristotle University Of Thessaloniki (AUTH); Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης (ΑΠΘ); 2017. [cited 2019 Jul 21]. Available from: http://hdl.handle.net/10442/hedi/41005.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Kapetanou A. Η επίδραση των από του στόματος χορηγούμενων αντιπηκτικών φαρμάκων στην οστική ενσωμάτωση ορθοπαιδικών εμφυτευμάτων: πειραματική μελέτη σε επίμυες. [Thesis]. Aristotle University Of Thessaloniki (AUTH); Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης (ΑΠΘ); 2017. Available from: http://hdl.handle.net/10442/hedi/41005

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Debrecen

9. Czibere, Nóra. Tartós antikoaguláns kezelés a háziorvosi praxisban .

Degree: DE – Általános Orvostudományi Kar, University of Debrecen

 A tartós antikoaguláns kezelés világszerte több millió embert érint. Munkája során minden gyakorló orvos, így a háziorvos is találkozik az antikoaguláns terápia nehézségeivel. Hosszú évtizedeken… (more)

Subjects/Keywords: antikoaguláns; kumarin; heparin; rivaroxaban; dabigatran

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Czibere, N. (n.d.). Tartós antikoaguláns kezelés a háziorvosi praxisban . (Thesis). University of Debrecen. Retrieved from http://hdl.handle.net/2437/230003

Note: this citation may be lacking information needed for this citation format:
No year of publication.
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Czibere, Nóra. “Tartós antikoaguláns kezelés a háziorvosi praxisban .” Thesis, University of Debrecen. Accessed July 21, 2019. http://hdl.handle.net/2437/230003.

Note: this citation may be lacking information needed for this citation format:
No year of publication.
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Czibere, Nóra. “Tartós antikoaguláns kezelés a háziorvosi praxisban .” Web. 21 Jul 2019.

Note: this citation may be lacking information needed for this citation format:
No year of publication.

Vancouver:

Czibere N. Tartós antikoaguláns kezelés a háziorvosi praxisban . [Internet] [Thesis]. University of Debrecen; [cited 2019 Jul 21]. Available from: http://hdl.handle.net/2437/230003.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
No year of publication.

Council of Science Editors:

Czibere N. Tartós antikoaguláns kezelés a háziorvosi praxisban . [Thesis]. University of Debrecen; Available from: http://hdl.handle.net/2437/230003

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
No year of publication.

10. Rocha, Helena Clarisse Mota Fiuza da. Novos anticoagulantes orais.

Degree: 2015, Universidade Fernando Pessoa

Projeto de Pós-Graduação/Dissertação apresentado à Universidade Fernando Pessoa como parte dos requisitos para obtenção do grau de Mestre em Ciências Farmacêuticas

Durante longos anos, os… (more)

Subjects/Keywords: Apixabano; Dabigatrano; Fator Xa; Rivaroxabano; Trombina; Apixaban; Dabigatran; Factor Xa; Rivaroxaban; Thrombin

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Rocha, H. C. M. F. d. (2015). Novos anticoagulantes orais. (Thesis). Universidade Fernando Pessoa. Retrieved from http://www.rcaap.pt/detail.jsp?id=oai:bdigital.ufp.pt:10284/5306

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Rocha, Helena Clarisse Mota Fiuza da. “Novos anticoagulantes orais.” 2015. Thesis, Universidade Fernando Pessoa. Accessed July 21, 2019. http://www.rcaap.pt/detail.jsp?id=oai:bdigital.ufp.pt:10284/5306.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Rocha, Helena Clarisse Mota Fiuza da. “Novos anticoagulantes orais.” 2015. Web. 21 Jul 2019.

Vancouver:

Rocha HCMFd. Novos anticoagulantes orais. [Internet] [Thesis]. Universidade Fernando Pessoa; 2015. [cited 2019 Jul 21]. Available from: http://www.rcaap.pt/detail.jsp?id=oai:bdigital.ufp.pt:10284/5306.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Rocha HCMFd. Novos anticoagulantes orais. [Thesis]. Universidade Fernando Pessoa; 2015. Available from: http://www.rcaap.pt/detail.jsp?id=oai:bdigital.ufp.pt:10284/5306

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Illinois – Chicago

11. Manzoor, Beenish S. Navigating Safety of Anticoagulant Use From Precision Medicine to Direct Oral Anticoagulants.

Degree: 2017, University of Illinois – Chicago

 Background: This dissertation focuses on assessing avenues for safe delivery of oral anticoagulants. In that, three studies have been undertaken to address gaps in practice… (more)

Subjects/Keywords: anticoagulants; anticoagulation; safety; warfarin; dabigatran; rivaroxaban; apixaban; direct oral anticoagulants; pharmacogenetics; adherence

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Manzoor, B. S. (2017). Navigating Safety of Anticoagulant Use From Precision Medicine to Direct Oral Anticoagulants. (Thesis). University of Illinois – Chicago. Retrieved from http://hdl.handle.net/10027/22225

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Manzoor, Beenish S. “Navigating Safety of Anticoagulant Use From Precision Medicine to Direct Oral Anticoagulants.” 2017. Thesis, University of Illinois – Chicago. Accessed July 21, 2019. http://hdl.handle.net/10027/22225.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Manzoor, Beenish S. “Navigating Safety of Anticoagulant Use From Precision Medicine to Direct Oral Anticoagulants.” 2017. Web. 21 Jul 2019.

Vancouver:

Manzoor BS. Navigating Safety of Anticoagulant Use From Precision Medicine to Direct Oral Anticoagulants. [Internet] [Thesis]. University of Illinois – Chicago; 2017. [cited 2019 Jul 21]. Available from: http://hdl.handle.net/10027/22225.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Manzoor BS. Navigating Safety of Anticoagulant Use From Precision Medicine to Direct Oral Anticoagulants. [Thesis]. University of Illinois – Chicago; 2017. Available from: http://hdl.handle.net/10027/22225

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Debrecen

12. Melleby, Nanna Kristine. New developments in oral anticoagulation .

Degree: DE – Általános Orvostudományi Kar, University of Debrecen

 The thesis is focused on stroke prevention in patients suffering from non-valvular atrial fibrillation, using the new oral anticoagulants. It contains descriptions of some of… (more)

Subjects/Keywords: NOAC; Rivaroxaban; Apixaban; Dabigatran; Atrial fibrillation

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Melleby, N. K. (n.d.). New developments in oral anticoagulation . (Thesis). University of Debrecen. Retrieved from http://hdl.handle.net/2437/213414

Note: this citation may be lacking information needed for this citation format:
No year of publication.
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Melleby, Nanna Kristine. “New developments in oral anticoagulation .” Thesis, University of Debrecen. Accessed July 21, 2019. http://hdl.handle.net/2437/213414.

Note: this citation may be lacking information needed for this citation format:
No year of publication.
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Melleby, Nanna Kristine. “New developments in oral anticoagulation .” Web. 21 Jul 2019.

Note: this citation may be lacking information needed for this citation format:
No year of publication.

Vancouver:

Melleby NK. New developments in oral anticoagulation . [Internet] [Thesis]. University of Debrecen; [cited 2019 Jul 21]. Available from: http://hdl.handle.net/2437/213414.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
No year of publication.

Council of Science Editors:

Melleby NK. New developments in oral anticoagulation . [Thesis]. University of Debrecen; Available from: http://hdl.handle.net/2437/213414

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
No year of publication.


University of Debrecen

13. Pituk, Dóra. Az új orális antikoagulánsok laboratóriumi monitorozása .

Degree: DE – Általános Orvostudományi Kar, University of Debrecen

 A diplomamunkámban az új típusú orális antikoaguláns készítmények (NOA) monitorozásának laboratóriumi lehetőségeit és a rutin haemostasis paraméterekre gyakorolt hatásait foglaltuk össze. A témaválasztás fontos és… (more)

Subjects/Keywords: NOACs; DOACs; laboratóriumi monitorozás; dabigatran; rivaroxaban

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Pituk, D. (n.d.). Az új orális antikoagulánsok laboratóriumi monitorozása . (Thesis). University of Debrecen. Retrieved from http://hdl.handle.net/2437/204792

Note: this citation may be lacking information needed for this citation format:
No year of publication.
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Pituk, Dóra. “Az új orális antikoagulánsok laboratóriumi monitorozása .” Thesis, University of Debrecen. Accessed July 21, 2019. http://hdl.handle.net/2437/204792.

Note: this citation may be lacking information needed for this citation format:
No year of publication.
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Pituk, Dóra. “Az új orális antikoagulánsok laboratóriumi monitorozása .” Web. 21 Jul 2019.

Note: this citation may be lacking information needed for this citation format:
No year of publication.

Vancouver:

Pituk D. Az új orális antikoagulánsok laboratóriumi monitorozása . [Internet] [Thesis]. University of Debrecen; [cited 2019 Jul 21]. Available from: http://hdl.handle.net/2437/204792.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
No year of publication.

Council of Science Editors:

Pituk D. Az új orális antikoagulánsok laboratóriumi monitorozása . [Thesis]. University of Debrecen; Available from: http://hdl.handle.net/2437/204792

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
No year of publication.


University of Debrecen

14. Móricz, Vivien. Modern orális antikoaguláns terápia .

Degree: DE – OEC – Gyógyszerésztudományi Kar, University of Debrecen

 Évtizedeken át a warfarin volt a legjobb orális véralvadásgátló, nagyon hatékony terápiának bizonyult, azonban sok beteg és orvos kívánja azt, hogy legyen más terápiásan választható… (more)

Subjects/Keywords: modern; orális véralvadásgátlók; rivaroxaban; dabigatran etexilat

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Móricz, V. (n.d.). Modern orális antikoaguláns terápia . (Thesis). University of Debrecen. Retrieved from http://hdl.handle.net/2437/227865

Note: this citation may be lacking information needed for this citation format:
No year of publication.
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Móricz, Vivien. “Modern orális antikoaguláns terápia .” Thesis, University of Debrecen. Accessed July 21, 2019. http://hdl.handle.net/2437/227865.

Note: this citation may be lacking information needed for this citation format:
No year of publication.
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Móricz, Vivien. “Modern orális antikoaguláns terápia .” Web. 21 Jul 2019.

Note: this citation may be lacking information needed for this citation format:
No year of publication.

Vancouver:

Móricz V. Modern orális antikoaguláns terápia . [Internet] [Thesis]. University of Debrecen; [cited 2019 Jul 21]. Available from: http://hdl.handle.net/2437/227865.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
No year of publication.

Council of Science Editors:

Móricz V. Modern orális antikoaguláns terápia . [Thesis]. University of Debrecen; Available from: http://hdl.handle.net/2437/227865

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
No year of publication.


University of Debrecen

15. Losonczy, Anita. Az új orális antikoagulánsok hatása a thrombin generációra .

Degree: DE – Általános Orvostudományi Kar, University of Debrecen

 A diplomadolgozat készítésének célja a Xarelto kezelt betegek plazmamintájában a Rivaroxaban-koncentráció meghatározása, majd ezen minták thrombin generációjában való eltérések vizsgálata kontroll plazmákhoz és Syncumar kezelt… (more)

Subjects/Keywords: új orális antikoagulánsok; rivaroxaban; thrombin generációs teszt

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Losonczy, A. (n.d.). Az új orális antikoagulánsok hatása a thrombin generációra . (Thesis). University of Debrecen. Retrieved from http://hdl.handle.net/2437/254767

Note: this citation may be lacking information needed for this citation format:
No year of publication.
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Losonczy, Anita. “Az új orális antikoagulánsok hatása a thrombin generációra .” Thesis, University of Debrecen. Accessed July 21, 2019. http://hdl.handle.net/2437/254767.

Note: this citation may be lacking information needed for this citation format:
No year of publication.
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Losonczy, Anita. “Az új orális antikoagulánsok hatása a thrombin generációra .” Web. 21 Jul 2019.

Note: this citation may be lacking information needed for this citation format:
No year of publication.

Vancouver:

Losonczy A. Az új orális antikoagulánsok hatása a thrombin generációra . [Internet] [Thesis]. University of Debrecen; [cited 2019 Jul 21]. Available from: http://hdl.handle.net/2437/254767.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
No year of publication.

Council of Science Editors:

Losonczy A. Az új orális antikoagulánsok hatása a thrombin generációra . [Thesis]. University of Debrecen; Available from: http://hdl.handle.net/2437/254767

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
No year of publication.


University of Western Ontario

16. Gulilat, Markus. Clinical And Pharmacogenetic Determinants Of Plasma Factor Xa Inhibitor Systemic Exposure.

Degree: 2018, University of Western Ontario

 Inhibition of blood coagulation via oral anticoagulant therapy is the mainstay for preventing a cardioembolic stroke in patients with atrial fibrillation (AF). Factor Xa inhibitors… (more)

Subjects/Keywords: Factor Xa inhibitor; apixaban; rivaroxaban; pharmacokinetics; interpatient variation; exome sequencing; single nucleotide variants; pharmacogenetics; Medical Genetics; Medical Pharmacology; Translational Medical Research

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Gulilat, M. (2018). Clinical And Pharmacogenetic Determinants Of Plasma Factor Xa Inhibitor Systemic Exposure. (Thesis). University of Western Ontario. Retrieved from https://ir.lib.uwo.ca/etd/5591

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Gulilat, Markus. “Clinical And Pharmacogenetic Determinants Of Plasma Factor Xa Inhibitor Systemic Exposure.” 2018. Thesis, University of Western Ontario. Accessed July 21, 2019. https://ir.lib.uwo.ca/etd/5591.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Gulilat, Markus. “Clinical And Pharmacogenetic Determinants Of Plasma Factor Xa Inhibitor Systemic Exposure.” 2018. Web. 21 Jul 2019.

Vancouver:

Gulilat M. Clinical And Pharmacogenetic Determinants Of Plasma Factor Xa Inhibitor Systemic Exposure. [Internet] [Thesis]. University of Western Ontario; 2018. [cited 2019 Jul 21]. Available from: https://ir.lib.uwo.ca/etd/5591.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Gulilat M. Clinical And Pharmacogenetic Determinants Of Plasma Factor Xa Inhibitor Systemic Exposure. [Thesis]. University of Western Ontario; 2018. Available from: https://ir.lib.uwo.ca/etd/5591

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Debrecen

17. Aune, Marit. New Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation compared to Warfarin .

Degree: DE – Általános Orvostudományi Kar, University of Debrecen

 This thesis focus on the New Oral Anticoagulants for Stroke prevention in Atrial Fibrillation, with a short description of their clinical pharmacologic properties and adverse… (more)

Subjects/Keywords: Atrial Fibrillation Stroke NOACs Dabigatran Apixaban Rivaroxaban Warfarin

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Aune, M. (n.d.). New Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation compared to Warfarin . (Thesis). University of Debrecen. Retrieved from http://hdl.handle.net/2437/218729

Note: this citation may be lacking information needed for this citation format:
No year of publication.
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Aune, Marit. “New Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation compared to Warfarin .” Thesis, University of Debrecen. Accessed July 21, 2019. http://hdl.handle.net/2437/218729.

Note: this citation may be lacking information needed for this citation format:
No year of publication.
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Aune, Marit. “New Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation compared to Warfarin .” Web. 21 Jul 2019.

Note: this citation may be lacking information needed for this citation format:
No year of publication.

Vancouver:

Aune M. New Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation compared to Warfarin . [Internet] [Thesis]. University of Debrecen; [cited 2019 Jul 21]. Available from: http://hdl.handle.net/2437/218729.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
No year of publication.

Council of Science Editors:

Aune M. New Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation compared to Warfarin . [Thesis]. University of Debrecen; Available from: http://hdl.handle.net/2437/218729

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
No year of publication.


Université de Sherbrooke

18. Dault, Roxanne. Portrait de l’usage des anticoagulants et facteurs associés au choix de ceux-ci pour le traitement de la thromboembolie veineuse .

Degree: 2015, Université de Sherbrooke

 Depuis déjà quelques années au Canada, l’arrivée progressive de nouveaux anticoagulants oraux (NACO) propose des options dans le traitement de la thromboembolie veineuse (TEV). Le… (more)

Subjects/Keywords: Thromboembolie veineuse; Thrombose veineuse profonde; Embolie pulmonaire; Anticoagulants; Rivaroxaban; Warfarine; Facteurs associés au choix de traitement

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Dault, R. (2015). Portrait de l’usage des anticoagulants et facteurs associés au choix de ceux-ci pour le traitement de la thromboembolie veineuse . (Masters Thesis). Université de Sherbrooke. Retrieved from http://hdl.handle.net/11143/7594

Chicago Manual of Style (16th Edition):

Dault, Roxanne. “Portrait de l’usage des anticoagulants et facteurs associés au choix de ceux-ci pour le traitement de la thromboembolie veineuse .” 2015. Masters Thesis, Université de Sherbrooke. Accessed July 21, 2019. http://hdl.handle.net/11143/7594.

MLA Handbook (7th Edition):

Dault, Roxanne. “Portrait de l’usage des anticoagulants et facteurs associés au choix de ceux-ci pour le traitement de la thromboembolie veineuse .” 2015. Web. 21 Jul 2019.

Vancouver:

Dault R. Portrait de l’usage des anticoagulants et facteurs associés au choix de ceux-ci pour le traitement de la thromboembolie veineuse . [Internet] [Masters thesis]. Université de Sherbrooke; 2015. [cited 2019 Jul 21]. Available from: http://hdl.handle.net/11143/7594.

Council of Science Editors:

Dault R. Portrait de l’usage des anticoagulants et facteurs associés au choix de ceux-ci pour le traitement de la thromboembolie veineuse . [Masters Thesis]. Université de Sherbrooke; 2015. Available from: http://hdl.handle.net/11143/7594

19. Ribeiro, Maria João de Castro Martins Oliveira. Avaliação da adesão à terapêutica com rivaroxabano versus enoxaparina.

Degree: 2013, RCAAP

 A presente dissertação encontra-se dividida em dois capítulos. O primeiro capítulo é relativo à investigação desenvolvida no âmbito do estudo da adesão à terapêutica anticoagulante… (more)

Subjects/Keywords: Terapêutica anticoagulante oral; Tromboembolismo venoso; Artroplastia da anca; Artroplastia do joelho; Enoxaparina; Rivaroxaban; Terapêutica anticoagulante subcutânea

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Ribeiro, M. J. d. C. M. O. (2013). Avaliação da adesão à terapêutica com rivaroxabano versus enoxaparina. (Thesis). RCAAP. Retrieved from https://www.rcaap.pt/detail.jsp?id=oai:ubibliorum.ubi.pt:10400.6/3121

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Ribeiro, Maria João de Castro Martins Oliveira. “Avaliação da adesão à terapêutica com rivaroxabano versus enoxaparina.” 2013. Thesis, RCAAP. Accessed July 21, 2019. https://www.rcaap.pt/detail.jsp?id=oai:ubibliorum.ubi.pt:10400.6/3121.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Ribeiro, Maria João de Castro Martins Oliveira. “Avaliação da adesão à terapêutica com rivaroxabano versus enoxaparina.” 2013. Web. 21 Jul 2019.

Vancouver:

Ribeiro MJdCMO. Avaliação da adesão à terapêutica com rivaroxabano versus enoxaparina. [Internet] [Thesis]. RCAAP; 2013. [cited 2019 Jul 21]. Available from: https://www.rcaap.pt/detail.jsp?id=oai:ubibliorum.ubi.pt:10400.6/3121.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Ribeiro MJdCMO. Avaliação da adesão à terapêutica com rivaroxabano versus enoxaparina. [Thesis]. RCAAP; 2013. Available from: https://www.rcaap.pt/detail.jsp?id=oai:ubibliorum.ubi.pt:10400.6/3121

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Helsinki

20. Koivula, Teija. Rivaroksabaanin kustannusvaikuttavuus varfariiniin verrattuna ei-läppäperäisen eteisvärinän aiheuttaman aivohalvauksen estossa: Järjestelmällinen kirjallisuuskatsaus.

Degree: Farmaceutiska fakulteten, 2017, University of Helsinki

 Atrial fibrillation is the most common sustained cardiac arythmia. It has been estimated that there will be 14 to 17 million atrial fibrillation patients in… (more)

Subjects/Keywords: cost-effectiveness; rivaroxaban; warfarin; novel oral anticoagulants; atrial fibrillation; stroke; rivaroksabaani; varfariini; uudet oraaliset antikoagulantit; eteisvärinä; aivohalvaus; kustannusvaikuttavuus; Socialfarmaci; Social Pharmacy; Sosiaalifarmasia; cost-effectiveness; rivaroxaban; warfarin; novel oral anticoagulants; atrial fibrillation; stroke; rivaroksabaani; varfariini; uudet oraaliset antikoagulantit; eteisvärinä; aivohalvaus; kustannusvaikuttavuus

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Koivula, T. (2017). Rivaroksabaanin kustannusvaikuttavuus varfariiniin verrattuna ei-läppäperäisen eteisvärinän aiheuttaman aivohalvauksen estossa: Järjestelmällinen kirjallisuuskatsaus. (Masters Thesis). University of Helsinki. Retrieved from http://hdl.handle.net/10138/199520

Chicago Manual of Style (16th Edition):

Koivula, Teija. “Rivaroksabaanin kustannusvaikuttavuus varfariiniin verrattuna ei-läppäperäisen eteisvärinän aiheuttaman aivohalvauksen estossa: Järjestelmällinen kirjallisuuskatsaus.” 2017. Masters Thesis, University of Helsinki. Accessed July 21, 2019. http://hdl.handle.net/10138/199520.

MLA Handbook (7th Edition):

Koivula, Teija. “Rivaroksabaanin kustannusvaikuttavuus varfariiniin verrattuna ei-läppäperäisen eteisvärinän aiheuttaman aivohalvauksen estossa: Järjestelmällinen kirjallisuuskatsaus.” 2017. Web. 21 Jul 2019.

Vancouver:

Koivula T. Rivaroksabaanin kustannusvaikuttavuus varfariiniin verrattuna ei-läppäperäisen eteisvärinän aiheuttaman aivohalvauksen estossa: Järjestelmällinen kirjallisuuskatsaus. [Internet] [Masters thesis]. University of Helsinki; 2017. [cited 2019 Jul 21]. Available from: http://hdl.handle.net/10138/199520.

Council of Science Editors:

Koivula T. Rivaroksabaanin kustannusvaikuttavuus varfariiniin verrattuna ei-läppäperäisen eteisvärinän aiheuttaman aivohalvauksen estossa: Järjestelmällinen kirjallisuuskatsaus. [Masters Thesis]. University of Helsinki; 2017. Available from: http://hdl.handle.net/10138/199520

21. 関, 要. Demeanor of rivaroxaban in activated/inactivated FXa. : 凝固第X因子活性時 / 非活性時におけるRivaroxabanの振る舞い.

Degree: 博士(医学), 2018, Saitama Medical University / 埼玉医科大学

Activated factor X (FXa) plays an important role in thrombin generation and inflammation. Factor X is not converted constitutively to FXa, but only after intrinsic… (more)

Subjects/Keywords: Cells, Cultured; Chemokine CCL2; Factor Xa; Factor Xa Inhibitors; Human Umbilical Vein Endothelial Cells; Humans; Intercellular Adhesion Molecule-1; Interleukin-8; Oligonucleotide Array Sequence Analysis; Receptors, Proteinase-Activated; Rivaroxaban

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

関, . (2018). Demeanor of rivaroxaban in activated/inactivated FXa. : 凝固第X因子活性時 / 非活性時におけるRivaroxabanの振る舞い. (Thesis). Saitama Medical University / 埼玉医科大学. Retrieved from http://id.nii.ac.jp/1386/00000609/

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

関, 要. “Demeanor of rivaroxaban in activated/inactivated FXa. : 凝固第X因子活性時 / 非活性時におけるRivaroxabanの振る舞い.” 2018. Thesis, Saitama Medical University / 埼玉医科大学. Accessed July 21, 2019. http://id.nii.ac.jp/1386/00000609/.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

関, 要. “Demeanor of rivaroxaban in activated/inactivated FXa. : 凝固第X因子活性時 / 非活性時におけるRivaroxabanの振る舞い.” 2018. Web. 21 Jul 2019.

Vancouver:

関 . Demeanor of rivaroxaban in activated/inactivated FXa. : 凝固第X因子活性時 / 非活性時におけるRivaroxabanの振る舞い. [Internet] [Thesis]. Saitama Medical University / 埼玉医科大学; 2018. [cited 2019 Jul 21]. Available from: http://id.nii.ac.jp/1386/00000609/.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

関 . Demeanor of rivaroxaban in activated/inactivated FXa. : 凝固第X因子活性時 / 非活性時におけるRivaroxabanの振る舞い. [Thesis]. Saitama Medical University / 埼玉医科大学; 2018. Available from: http://id.nii.ac.jp/1386/00000609/

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

22. Conversy, Bérénice. Etude d'un anticoagulant oral (le rivaroxaban) sur les paramètres hémostatiques de chiens en santé .

Degree: 2015, Université de Montréal

 Chez le chien, les thromboses représentent une complication majeure de nombreuses conditions qui sont revues dans ce manuscrit. L’arsenal thérapeutique actuel présente certaines limites: des… (more)

Subjects/Keywords: Coagulation; Rivaroxaban; Chien; Thrombose; Pharmacodynamie; Dog; Thrombosis; Pharmacodynamy

…47 IV- Le rivaroxaban ..49 1- Caractéristiques du produit… …disponibles dans l’espèce canine …56 4- Etude du rivaroxaban chez le chien… …l’évaluation du rivaroxaban chez le chien ….…59 vi PARTIE 2 : Rivaroxaban demonstrates in vitro… …In vivo evaluation of the effects of rivaroxaban on coagulation parameters in healthy dogs… …35 Tableau IV : Comparaison des données pharmacocinétiques et métaboliques du rivaroxaban… 

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Conversy, B. (2015). Etude d'un anticoagulant oral (le rivaroxaban) sur les paramètres hémostatiques de chiens en santé . (Thesis). Université de Montréal. Retrieved from http://hdl.handle.net/1866/12613

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Conversy, Bérénice. “Etude d'un anticoagulant oral (le rivaroxaban) sur les paramètres hémostatiques de chiens en santé .” 2015. Thesis, Université de Montréal. Accessed July 21, 2019. http://hdl.handle.net/1866/12613.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Conversy, Bérénice. “Etude d'un anticoagulant oral (le rivaroxaban) sur les paramètres hémostatiques de chiens en santé .” 2015. Web. 21 Jul 2019.

Vancouver:

Conversy B. Etude d'un anticoagulant oral (le rivaroxaban) sur les paramètres hémostatiques de chiens en santé . [Internet] [Thesis]. Université de Montréal; 2015. [cited 2019 Jul 21]. Available from: http://hdl.handle.net/1866/12613.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Conversy B. Etude d'un anticoagulant oral (le rivaroxaban) sur les paramètres hémostatiques de chiens en santé . [Thesis]. Université de Montréal; 2015. Available from: http://hdl.handle.net/1866/12613

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

23. Ferreira, João Pedro Rosa. Análise custo-efectividade dos novos anticoagulantes orais.

Degree: 2014, Repositório Científico Lusófona

Os novos anticoagulantes orais são opções emergentes para a prevenção e tratamento das doenças tromboembólicas. São cada vez mais usados na prática clínica pela facilidade… (more)

Subjects/Keywords: FARMACOLOGIA; MEDICAMENTOS; ANTICOAGULANTES; DABIGATRANO; RIVAROXABANO; APIXABANO; PHARMACOLOGY; DRUGS; ANTICOAGULANTS; DABIGATRAN; RIVAROXABAN; APIXABAN; MESTRADO INTEGRADO EM CIÊNCIAS FARMACÊUTICAS; ANÁLISE DE CUSTO-EFETIVIDADE; COST-EFFECTIVENESS ANALYSIS; CIÊNCIAS FARMACÊUTICAS; PHARMACEUTICAL SCIENCES

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Ferreira, J. P. R. (2014). Análise custo-efectividade dos novos anticoagulantes orais. (Thesis). Repositório Científico Lusófona. Retrieved from https://www.rcaap.pt/detail.jsp?id=oai:recil.grupolusofona.pt:10437/4711

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Ferreira, João Pedro Rosa. “Análise custo-efectividade dos novos anticoagulantes orais.” 2014. Thesis, Repositório Científico Lusófona. Accessed July 21, 2019. https://www.rcaap.pt/detail.jsp?id=oai:recil.grupolusofona.pt:10437/4711.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Ferreira, João Pedro Rosa. “Análise custo-efectividade dos novos anticoagulantes orais.” 2014. Web. 21 Jul 2019.

Vancouver:

Ferreira JPR. Análise custo-efectividade dos novos anticoagulantes orais. [Internet] [Thesis]. Repositório Científico Lusófona; 2014. [cited 2019 Jul 21]. Available from: https://www.rcaap.pt/detail.jsp?id=oai:recil.grupolusofona.pt:10437/4711.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Ferreira JPR. Análise custo-efectividade dos novos anticoagulantes orais. [Thesis]. Repositório Científico Lusófona; 2014. Available from: https://www.rcaap.pt/detail.jsp?id=oai:recil.grupolusofona.pt:10437/4711

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

24. Plácido, Ana Isabel Pereira. Anticoagulantes orais.

Degree: 2016, Universidade Fernando Pessoa

Os novos anticoagulantes orais representam uma inovação terapêutica anticoagulante, tendo obtido recentemente aprovação para várias indicações clínicas. A varfarina foi um dos primeiros anticoagulantes orais… (more)

Subjects/Keywords: Novos anticoagulantes; Antagonistas da vitamina K; Varfarina; Fibrilação auricular; Anticoagulantes orais; Tromboembolismo venoso; Dabigatrano; Rivaroxabano; Apixabano; New anticoagulants; Vitamin K antagonists; Warfarin; Atrial fibrillation; Oral anticoagulants; Venous thromboembolism; Dabigatran; Rivaroxaban; Apixaban; Domínio/Área Científica::Ciências Médicas::Medicina Básica

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Plácido, A. I. P. (2016). Anticoagulantes orais. (Thesis). Universidade Fernando Pessoa. Retrieved from http://www.rcaap.pt/detail.jsp?id=oai:bdigital.ufp.pt:10284/5835

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Plácido, Ana Isabel Pereira. “Anticoagulantes orais.” 2016. Thesis, Universidade Fernando Pessoa. Accessed July 21, 2019. http://www.rcaap.pt/detail.jsp?id=oai:bdigital.ufp.pt:10284/5835.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Plácido, Ana Isabel Pereira. “Anticoagulantes orais.” 2016. Web. 21 Jul 2019.

Vancouver:

Plácido AIP. Anticoagulantes orais. [Internet] [Thesis]. Universidade Fernando Pessoa; 2016. [cited 2019 Jul 21]. Available from: http://www.rcaap.pt/detail.jsp?id=oai:bdigital.ufp.pt:10284/5835.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Plácido AIP. Anticoagulantes orais. [Thesis]. Universidade Fernando Pessoa; 2016. Available from: http://www.rcaap.pt/detail.jsp?id=oai:bdigital.ufp.pt:10284/5835

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Debrecen

25. Tornyi, Fanni. Az új orális antikoagulánsok klinikai felhasználásának lehetőségei .

Degree: DE – Általános Orvostudományi Kar, University of Debrecen

 A pitvarfibrilláció a leggyakoribb szívritmuszavar napjainkban, melynek előfordulása folyamatos növekedést mutat az elmúlt évtizedekben. Terápiája ma is komoly kihívást jelent. A szívizom arrythmiás összehúzódása következtében… (more)

Subjects/Keywords: antikoaguláns; NOAC; véralvadás; pitvarfibrilláció; szisztémás embólia; dabigatran; rivaroxaban; apixaban; warfarin; RE-LY; ROCKET-AF; ARISTOTLE

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Tornyi, F. (n.d.). Az új orális antikoagulánsok klinikai felhasználásának lehetőségei . (Thesis). University of Debrecen. Retrieved from http://hdl.handle.net/2437/242888

Note: this citation may be lacking information needed for this citation format:
No year of publication.
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Tornyi, Fanni. “Az új orális antikoagulánsok klinikai felhasználásának lehetőségei .” Thesis, University of Debrecen. Accessed July 21, 2019. http://hdl.handle.net/2437/242888.

Note: this citation may be lacking information needed for this citation format:
No year of publication.
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Tornyi, Fanni. “Az új orális antikoagulánsok klinikai felhasználásának lehetőségei .” Web. 21 Jul 2019.

Note: this citation may be lacking information needed for this citation format:
No year of publication.

Vancouver:

Tornyi F. Az új orális antikoagulánsok klinikai felhasználásának lehetőségei . [Internet] [Thesis]. University of Debrecen; [cited 2019 Jul 21]. Available from: http://hdl.handle.net/2437/242888.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
No year of publication.

Council of Science Editors:

Tornyi F. Az új orális antikoagulánsok klinikai felhasználásának lehetőségei . [Thesis]. University of Debrecen; Available from: http://hdl.handle.net/2437/242888

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
No year of publication.

26. Dault, Roxanne. Portrait de l’usage des anticoagulants et facteurs associés au choix de ceux-ci pour le traitement de la thromboembolie veineuse.

Degree: M. Sc., Sciences cliniques, 2015, Université de Sherbrooke

 Depuis déjà quelques années au Canada, l’arrivée progressive de nouveaux anticoagulants oraux (NACO) propose des options dans le traitement de la thromboembolie veineuse (TEV). Le… (more)

Subjects/Keywords: Thromboembolie veineuse; Thrombose veineuse profonde; Embolie pulmonaire; Anticoagulants; Rivaroxaban; Warfarine; Facteurs associés au choix de traitement

…que le dabigatran, le rivaroxaban, et l’apixaban sur le marché pharmaceutique propose des… …anticoagulants utilisés pour traiter cette maladie au CHUS suite l’arrivée du rivaroxaban (seul… …rivaroxaban et l’apixaban. Le rivaroxaban a été le premier NACO approuvé au Canada pour le… …Health Canada, 13 2014c; Health Canada, 2014d). Par contre, le rivaroxaban n’a été… …pour cette indication. De plus, lors de la réalisation de la présente étude, le rivaroxaban… 

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Dault, R. (2015). Portrait de l’usage des anticoagulants et facteurs associés au choix de ceux-ci pour le traitement de la thromboembolie veineuse. (Masters Thesis). Université de Sherbrooke. Retrieved from http://www.collectionscanada.gc.ca/obj/thesescanada/vol2/QSHERU/TC-QSHERU-11143_7594.pdf ; http://savoirs.usherbrooke.ca/bitstream/11143/7594/7/Dault_Roxanne_MSc_2015.pdf

Chicago Manual of Style (16th Edition):

Dault, Roxanne. “Portrait de l’usage des anticoagulants et facteurs associés au choix de ceux-ci pour le traitement de la thromboembolie veineuse.” 2015. Masters Thesis, Université de Sherbrooke. Accessed July 21, 2019. http://www.collectionscanada.gc.ca/obj/thesescanada/vol2/QSHERU/TC-QSHERU-11143_7594.pdf ; http://savoirs.usherbrooke.ca/bitstream/11143/7594/7/Dault_Roxanne_MSc_2015.pdf.

MLA Handbook (7th Edition):

Dault, Roxanne. “Portrait de l’usage des anticoagulants et facteurs associés au choix de ceux-ci pour le traitement de la thromboembolie veineuse.” 2015. Web. 21 Jul 2019.

Vancouver:

Dault R. Portrait de l’usage des anticoagulants et facteurs associés au choix de ceux-ci pour le traitement de la thromboembolie veineuse. [Internet] [Masters thesis]. Université de Sherbrooke; 2015. [cited 2019 Jul 21]. Available from: http://www.collectionscanada.gc.ca/obj/thesescanada/vol2/QSHERU/TC-QSHERU-11143_7594.pdf ; http://savoirs.usherbrooke.ca/bitstream/11143/7594/7/Dault_Roxanne_MSc_2015.pdf.

Council of Science Editors:

Dault R. Portrait de l’usage des anticoagulants et facteurs associés au choix de ceux-ci pour le traitement de la thromboembolie veineuse. [Masters Thesis]. Université de Sherbrooke; 2015. Available from: http://www.collectionscanada.gc.ca/obj/thesescanada/vol2/QSHERU/TC-QSHERU-11143_7594.pdf ; http://savoirs.usherbrooke.ca/bitstream/11143/7594/7/Dault_Roxanne_MSc_2015.pdf

.